My diognosis is absence of nitabisha fibrinoid layer Give me the featu

My diognosis is absence of nitabisha fibrinoid layer Give me the features

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Loading Image

Reading File

Finding Sources

Here is a complete answer based on Creasy & Resnik's Maternal-Fetal Medicine:

Absence of Nitabuch's Fibrinoid Layer = Placenta Accreta Spectrum (PAS)

What is Nitabuch's Layer?

Nitabuch's fibrinoid layer is a band of fibrinoid material that forms the normal boundary between trophoblastic tissue and the maternal decidua basalis at the placental floor. In normal implantation, anchoring villi encroach on - but do NOT penetrate through - this membrane. It acts as a physiologic barrier that limits trophoblastic invasion.

Normal vs. Absent Nitabuch Layer (Histology)

Normal placental implantation (A) vs. placenta accreta with no decidua (B)

(A) Normal - Anchoring villi, Nitabuch membrane, and decidua basalis are all present at the placental floor. (B) Placenta Accreta - No decidua, no Nitabuch layer; trophoblasts invade directly into myometrium.

Features of Absence of Nitabuch's Fibrinoid Layer

The absence of this layer defines the Placenta Accreta Spectrum (PAS), with three grades based on depth of invasion:

Grade	Term	Feature
1	Placenta Accreta	Trophoblast attaches to myometrium with NO intervening decidua; invasion just beyond Nitabuch boundary
2	Placenta Increta	Invasion extends INTO the myometrium
3	Placenta Percreta	Invasion BEYOND uterine serosa (may involve bladder or other pelvic organs)

Key Clinical & Pathological Features

Histology:

No Nitabuch fibrinoid membrane visible
No decidua basalis between villi and myometrium ("no decidua" sign)
Trophoblasts in direct contact with or invading myometrial muscle fibers

Risk factors (why the layer is absent):

Prior cesarean section - most common cause (risk >60% with previa + 3 or more cesareans)
Placenta previa
Other uterine surgeries: endometrial ablation, myomectomy, uterine curettage
Pelvic radiation
IVF, advanced maternal age, smoking, increased parity

Ultrasound features:

Loss of normal hypoechoic boundary between placenta and bladder (represents absent myometrial/decidual layer)
Intraplacental sonolucent spaces adjacent to uterine wall
Turbulent flow and increased vascularity at the placenta-uterus interface on Doppler
Obliteration of the well-delineated bladder wall
Sensitivity ~55-90% depending on operator expertise

MRI features:

Useful for posterior placenta or assessing deep myometrial/bladder involvement
High accuracy for confirming diagnosis
Gadolinium may improve detection but carries fetal risk

Clinical consequences:

Failure of placenta to separate normally after delivery
Massive intraoperative hemorrhage
Most common indication for emergency peripartum hysterectomy
High maternal morbidity

Management:

Preferred treatment: planned cesarean delivery + hysterectomy (peripartum)
Multidisciplinary team approach
Pre-delivery diagnosis markedly reduces morbidity
Planned delivery at 34-35 weeks after corticosteroid administration
Conservative management (leaving placenta in situ) is possible in selected cases

Source: Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice, Chapter 43 - Placenta Accreta Spectrum, p. 1021

This is a shared conversation. Sign in to Orris to start your own chat.